Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Aerie Pharmaceuticals Stock Price (Quote) NASDAQ:AERI
$10.23 ( -3.40% ) Monday, 25th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $10.12 | $13.70 | Monday, 25th Oct 2021 AERI stock ended at $10.23. This is 3.4% less than the trading day before Friday, 22nd Oct 2021. During the day the stock fluctuated 6.03% from a day low at $10.12 to a day high of $10.73. |
| 90 days | $10.12 | $17.21 | |
| 52 weeks | $9.51 | $21.30 |
Historical Aerie Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-25 | $10.54 | $10.73 | $10.12 | $10.23 | 775 597 |
| 2021-10-22 | $11.32 | $11.46 | $10.47 | $10.59 | 1 259 191 |
| 2021-10-21 | $11.69 | $11.93 | $11.25 | $11.46 | 1 386 537 |
| 2021-10-20 | $12.84 | $12.87 | $11.39 | $11.60 | 1 731 296 |
| 2021-10-19 | $12.76 | $13.29 | $12.65 | $13.16 | 210 313 |
| 2021-10-18 | $13.06 | $13.27 | $12.75 | $12.79 | 598 074 |
| 2021-10-15 | $13.46 | $13.50 | $13.10 | $13.23 | 351 965 |
| 2021-10-14 | $13.13 | $13.45 | $12.83 | $13.33 | 818 978 |
| 2021-10-13 | $13.41 | $13.48 | $12.94 | $12.94 | 407 740 |
| 2021-10-12 | $13.19 | $13.70 | $12.64 | $13.28 | 844 941 |
| 2021-10-11 | $12.68 | $13.27 | $12.68 | $13.05 | 1 722 199 |
| 2021-10-08 | $12.13 | $12.68 | $12.00 | $12.59 | 514 900 |
| 2021-10-07 | $11.75 | $12.06 | $11.56 | $12.00 | 470 683 |
| 2021-10-06 | $11.45 | $11.98 | $11.45 | $11.63 | 358 838 |
| 2021-10-05 | $11.43 | $11.81 | $11.39 | $11.63 | 641 553 |
| 2021-10-04 | $11.34 | $11.66 | $11.21 | $11.34 | 432 603 |
| 2021-10-01 | $11.38 | $11.52 | $11.12 | $11.44 | 639 458 |
| 2021-09-30 | $11.27 | $11.54 | $11.14 | $11.40 | 267 441 |
| 2021-09-29 | $11.58 | $11.82 | $11.20 | $11.32 | 380 933 |
| 2021-09-28 | $11.85 | $12.00 | $11.45 | $11.49 | 998 447 |
| 2021-09-27 | $11.96 | $12.13 | $11.75 | $11.95 | 670 070 |
| 2021-09-24 | $12.18 | $12.35 | $11.75 | $11.79 | 296 747 |
| 2021-09-23 | $12.02 | $12.33 | $11.90 | $12.10 | 1 181 130 |
| 2021-09-22 | $12.32 | $12.39 | $11.75 | $11.92 | 945 335 |
| 2021-09-21 | $11.36 | $12.55 | $11.36 | $12.27 | 3 108 826 |
| 2021-09-20 | $12.69 | $12.77 | $11.35 | $11.59 | 1 384 023 |
| 2021-09-17 | $12.41 | $12.94 | $11.89 | $12.94 | 1 363 458 |
| 2021-09-16 | $13.70 | $13.70 | $11.00 | $12.34 | 6 339 746 |
| 2021-09-15 | $15.82 | $16.07 | $15.60 | $15.70 | 448 585 |
| 2021-09-14 | $15.69 | $16.10 | $15.33 | $15.79 | 657 474 |
| 2021-09-13 | $16.75 | $17.21 | $15.59 | $15.80 | 563 828 |
| 2021-09-10 | $16.07 | $16.75 | $15.28 | $16.63 | 1 150 406 |
| 2021-09-09 | $14.35 | $16.20 | $14.35 | $16.00 | 1 072 532 |
| 2021-09-08 | $14.26 | $14.67 | $14.04 | $14.43 | 328 646 |
| 2021-09-07 | $14.28 | $14.52 | $13.94 | $14.16 | 370 564 |
| 2021-09-03 | $14.82 | $14.83 | $14.19 | $14.34 | 220 505 |
| 2021-09-02 | $14.89 | $15.21 | $14.74 | $14.88 | 191 190 |
| 2021-09-01 | $14.90 | $15.27 | $14.66 | $14.83 | 197 454 |
| 2021-08-31 | $14.46 | $14.92 | $14.44 | $14.91 | 214 136 |
| 2021-08-30 | $14.65 | $14.89 | $14.48 | $14.52 | 251 419 |
| 2021-08-27 | $14.44 | $14.97 | $14.34 | $14.68 | 393 141 |
| 2021-08-26 | $14.71 | $14.82 | $14.26 | $14.35 | 185 971 |
| 2021-08-25 | $14.62 | $14.97 | $14.51 | $14.72 | 243 046 |
| 2021-08-24 | $14.77 | $14.92 | $14.45 | $14.64 | 194 767 |
| 2021-08-23 | $14.73 | $15.01 | $14.51 | $14.86 | 208 337 |
| 2021-08-20 | $13.96 | $14.62 | $13.84 | $14.50 | 361 631 |
| 2021-08-19 | $14.29 | $14.50 | $14.05 | $14.06 | 312 451 |
| 2021-08-18 | $14.84 | $14.84 | $14.41 | $14.43 | 185 260 |
| 2021-08-17 | $14.24 | $14.70 | $14.24 | $14.59 | 185 920 |
| 2021-08-16 | $14.58 | $14.68 | $14.29 | $14.47 | 210 789 |
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its product candidates include Rhopressa, a once-daily eye drop, which has completed Phase III registration trials for the reduction of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Roclatan, a once-dai... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
